Report cover image

Global Alternative to Antibiotics Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 197 Pages
SKU # APRC20356403

Description

Summary

According to APO Research, The global Alternative to Antibiotics market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Alternative to Antibiotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Alternative to Antibiotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Alternative to Antibiotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Alternative to Antibiotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Alternative to Antibiotics include DSM, BioGaia, Bioriginal, Biosearch Life, China-Biotics, Chr. Hansen, Danone, DuPont(Danisco) and Ganeden, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Alternative to Antibiotics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Alternative to Antibiotics, also provides the sales of main regions and countries. Of the upcoming market potential for Alternative to Antibiotics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Alternative to Antibiotics sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Alternative to Antibiotics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Alternative to Antibiotics sales, projected growth trends, production technology, application and end-user industry.

Alternative to Antibiotics Segment by Company

DSM
BioGaia
Bioriginal
Biosearch Life
China-Biotics
Chr. Hansen
Danone
DuPont(Danisco)
Ganeden
Glory Biotech
Greentech
Lallemand
Morinaga Milk Industry
Novozymes
Probi
Sabinsa
Synbiotech
UAS Laboratories
Valio
Yakult
Nestle
Alternative to Antibiotics Segment by Type

Antimicrobial Proteins
Bacteriophages
Probiotics
Other
Alternative to Antibiotics Segment by Application

Drugs
Food & Beverage
Dietary Supplements
Alternative to Antibiotics Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alternative to Antibiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Alternative to Antibiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alternative to Antibiotics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Alternative to Antibiotics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Alternative to Antibiotics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Alternative to Antibiotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Alternative to Antibiotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Table of Contents

197 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Alternative to Antibiotics Market Size, 2020 VS 2024 VS 2031
1.3 Global Alternative to Antibiotics Market Size Estimates and Forecasts (2020-2031)
1.4 Global Alternative to Antibiotics Sales Estimates and Forecasts (2020-2031)
1.5 Global Alternative to Antibiotics Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Alternative to Antibiotics Market Dynamics
2.1 Alternative to Antibiotics Industry Trends
2.2 Alternative to Antibiotics Industry Drivers
2.3 Alternative to Antibiotics Industry Opportunities and Challenges
2.4 Alternative to Antibiotics Industry Restraints
3 Alternative to Antibiotics Market by Manufacturers
3.1 Global Alternative to Antibiotics Revenue by Manufacturers (2020-2025)
3.2 Global Alternative to Antibiotics Sales by Manufacturers (2020-2025)
3.3 Global Alternative to Antibiotics Average Sales Price by Manufacturers (2020-2025)
3.4 Global Alternative to Antibiotics Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Alternative to Antibiotics Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Alternative to Antibiotics Manufacturers, Product Type & Application
3.7 Global Alternative to Antibiotics Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Alternative to Antibiotics Market CR5 and HHI
3.8.2 Global Top 5 and 10 Alternative to Antibiotics Players Market Share by Revenue in 2024
3.8.3 2024 Alternative to Antibiotics Tier 1, Tier 2, and Tier 3
4 Alternative to Antibiotics Market by Type
4.1 Alternative to Antibiotics Type Introduction
4.1.1 Antimicrobial Proteins
4.1.2 Bacteriophages
4.1.3 Probiotics
4.1.4 Other
4.2 Global Alternative to Antibiotics Sales by Type
4.2.1 Global Alternative to Antibiotics Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Alternative to Antibiotics Sales by Type (2020-2031)
4.2.3 Global Alternative to Antibiotics Sales Market Share by Type (2020-2031)
4.3 Global Alternative to Antibiotics Revenue by Type
4.3.1 Global Alternative to Antibiotics Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Alternative to Antibiotics Revenue by Type (2020-2031)
4.3.3 Global Alternative to Antibiotics Revenue Market Share by Type (2020-2031)
5 Alternative to Antibiotics Market by Application
5.1 Alternative to Antibiotics Application Introduction
5.1.1 Drugs
5.1.2 Food & Beverage
5.1.3 Dietary Supplements
5.2 Global Alternative to Antibiotics Sales by Application
5.2.1 Global Alternative to Antibiotics Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Alternative to Antibiotics Sales by Application (2020-2031)
5.2.3 Global Alternative to Antibiotics Sales Market Share by Application (2020-2031)
5.3 Global Alternative to Antibiotics Revenue by Application
5.3.1 Global Alternative to Antibiotics Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Alternative to Antibiotics Revenue by Application (2020-2031)
5.3.3 Global Alternative to Antibiotics Revenue Market Share by Application (2020-2031)
6 Global Alternative to Antibiotics Sales by Region
6.1 Global Alternative to Antibiotics Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Alternative to Antibiotics Sales by Region (2020-2031)
6.2.1 Global Alternative to Antibiotics Sales by Region (2020-2025)
6.2.2 Global Alternative to Antibiotics Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Alternative to Antibiotics Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Alternative to Antibiotics Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Alternative to Antibiotics Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Alternative to Antibiotics Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Alternative to Antibiotics Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Alternative to Antibiotics Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Alternative to Antibiotics Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Alternative to Antibiotics Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Alternative to Antibiotics Revenue by Region
7.1 Global Alternative to Antibiotics Revenue by Region
7.1.1 Global Alternative to Antibiotics Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Alternative to Antibiotics Revenue by Region (2020-2025)
7.1.3 Global Alternative to Antibiotics Revenue by Region (2026-2031)
7.1.4 Global Alternative to Antibiotics Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Alternative to Antibiotics Revenue (2020-2031)
7.2.2 North America Alternative to Antibiotics Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Alternative to Antibiotics Revenue (2020-2031)
7.3.2 Europe Alternative to Antibiotics Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Alternative to Antibiotics Revenue (2020-2031)
7.4.2 Asia-Pacific Alternative to Antibiotics Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Alternative to Antibiotics Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Alternative to Antibiotics Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 DSM
8.1.1 DSM Comapny Information
8.1.2 DSM Business Overview
8.1.3 DSM Alternative to Antibiotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 DSM Alternative to Antibiotics Product Portfolio
8.1.5 DSM Recent Developments
8.2 BioGaia
8.2.1 BioGaia Comapny Information
8.2.2 BioGaia Business Overview
8.2.3 BioGaia Alternative to Antibiotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 BioGaia Alternative to Antibiotics Product Portfolio
8.2.5 BioGaia Recent Developments
8.3 Bioriginal
8.3.1 Bioriginal Comapny Information
8.3.2 Bioriginal Business Overview
8.3.3 Bioriginal Alternative to Antibiotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Bioriginal Alternative to Antibiotics Product Portfolio
8.3.5 Bioriginal Recent Developments
8.4 Biosearch Life
8.4.1 Biosearch Life Comapny Information
8.4.2 Biosearch Life Business Overview
8.4.3 Biosearch Life Alternative to Antibiotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Biosearch Life Alternative to Antibiotics Product Portfolio
8.4.5 Biosearch Life Recent Developments
8.5 China-Biotics
8.5.1 China-Biotics Comapny Information
8.5.2 China-Biotics Business Overview
8.5.3 China-Biotics Alternative to Antibiotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 China-Biotics Alternative to Antibiotics Product Portfolio
8.5.5 China-Biotics Recent Developments
8.6 Chr. Hansen
8.6.1 Chr. Hansen Comapny Information
8.6.2 Chr. Hansen Business Overview
8.6.3 Chr. Hansen Alternative to Antibiotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Chr. Hansen Alternative to Antibiotics Product Portfolio
8.6.5 Chr. Hansen Recent Developments
8.7 Danone
8.7.1 Danone Comapny Information
8.7.2 Danone Business Overview
8.7.3 Danone Alternative to Antibiotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Danone Alternative to Antibiotics Product Portfolio
8.7.5 Danone Recent Developments
8.8 DuPont(Danisco)
8.8.1 DuPont(Danisco) Comapny Information
8.8.2 DuPont(Danisco) Business Overview
8.8.3 DuPont(Danisco) Alternative to Antibiotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 DuPont(Danisco) Alternative to Antibiotics Product Portfolio
8.8.5 DuPont(Danisco) Recent Developments
8.9 Ganeden
8.9.1 Ganeden Comapny Information
8.9.2 Ganeden Business Overview
8.9.3 Ganeden Alternative to Antibiotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Ganeden Alternative to Antibiotics Product Portfolio
8.9.5 Ganeden Recent Developments
8.10 Glory Biotech
8.10.1 Glory Biotech Comapny Information
8.10.2 Glory Biotech Business Overview
8.10.3 Glory Biotech Alternative to Antibiotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Glory Biotech Alternative to Antibiotics Product Portfolio
8.10.5 Glory Biotech Recent Developments
8.11 Greentech
8.11.1 Greentech Comapny Information
8.11.2 Greentech Business Overview
8.11.3 Greentech Alternative to Antibiotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Greentech Alternative to Antibiotics Product Portfolio
8.11.5 Greentech Recent Developments
8.12 Lallemand
8.12.1 Lallemand Comapny Information
8.12.2 Lallemand Business Overview
8.12.3 Lallemand Alternative to Antibiotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Lallemand Alternative to Antibiotics Product Portfolio
8.12.5 Lallemand Recent Developments
8.13 Morinaga Milk Industry
8.13.1 Morinaga Milk Industry Comapny Information
8.13.2 Morinaga Milk Industry Business Overview
8.13.3 Morinaga Milk Industry Alternative to Antibiotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.13.4 Morinaga Milk Industry Alternative to Antibiotics Product Portfolio
8.13.5 Morinaga Milk Industry Recent Developments
8.14 Novozymes
8.14.1 Novozymes Comapny Information
8.14.2 Novozymes Business Overview
8.14.3 Novozymes Alternative to Antibiotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.14.4 Novozymes Alternative to Antibiotics Product Portfolio
8.14.5 Novozymes Recent Developments
8.15 Probi
8.15.1 Probi Comapny Information
8.15.2 Probi Business Overview
8.15.3 Probi Alternative to Antibiotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.15.4 Probi Alternative to Antibiotics Product Portfolio
8.15.5 Probi Recent Developments
8.16 Sabinsa
8.16.1 Sabinsa Comapny Information
8.16.2 Sabinsa Business Overview
8.16.3 Sabinsa Alternative to Antibiotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.16.4 Sabinsa Alternative to Antibiotics Product Portfolio
8.16.5 Sabinsa Recent Developments
8.17 Synbiotech
8.17.1 Synbiotech Comapny Information
8.17.2 Synbiotech Business Overview
8.17.3 Synbiotech Alternative to Antibiotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.17.4 Synbiotech Alternative to Antibiotics Product Portfolio
8.17.5 Synbiotech Recent Developments
8.18 UAS Laboratories
8.18.1 UAS Laboratories Comapny Information
8.18.2 UAS Laboratories Business Overview
8.18.3 UAS Laboratories Alternative to Antibiotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.18.4 UAS Laboratories Alternative to Antibiotics Product Portfolio
8.18.5 UAS Laboratories Recent Developments
8.19 Valio
8.19.1 Valio Comapny Information
8.19.2 Valio Business Overview
8.19.3 Valio Alternative to Antibiotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.19.4 Valio Alternative to Antibiotics Product Portfolio
8.19.5 Valio Recent Developments
8.20 Yakult
8.20.1 Yakult Comapny Information
8.20.2 Yakult Business Overview
8.20.3 Yakult Alternative to Antibiotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.20.4 Yakult Alternative to Antibiotics Product Portfolio
8.20.5 Yakult Recent Developments
8.21 Nestle
8.21.1 Nestle Comapny Information
8.21.2 Nestle Business Overview
8.21.3 Nestle Alternative to Antibiotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.21.4 Nestle Alternative to Antibiotics Product Portfolio
8.21.5 Nestle Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Alternative to Antibiotics Value Chain Analysis
9.1.1 Alternative to Antibiotics Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Alternative to Antibiotics Production Mode & Process
9.2 Alternative to Antibiotics Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Alternative to Antibiotics Distributors
9.2.3 Alternative to Antibiotics Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.